Home›Ipratropium Bromide And Albuterol Sulfate

Ipratropium Bromide And Albuterol Sulfate

Also known as: Ipratropium Bromide And Albuterol Sulfate

Route: Respiratory (Inhalation)

Check Ipratropium Bromide And Albuterol Sulfate Interactions →

9 interactions on record

Ipratropium Bromide And Albuterol Sulfate has 9 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acidifying Agents, Monoamine Oxidase Inhibitors (Maois), Nonselective Beta-Adrenergic Antagonists. Patients taking Ipratropium Bromide And Albuterol Sulfate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 9
Major: 3
Moderate: 6

Major (3)

Ipratropium Bromide And Albuterol Sulfate + Acidifying Agents— Potential additive interaction with concomitantly used anticholinergic medications, may increase anticholinergic adverse…
Ipratropium Bromide And Albuterol Sulfate + Monoamine Oxidase Inhibitors (Maois)— Extreme caution advised; action of albuterol on cardiovascular system may be potentiated. Should not be used within 2 we…
Ipratropium Bromide And Albuterol Sulfate + Nonselective Beta-Adrenergic Antagonists— Increased risk of adverse cardiovascular effects with concomitant sympathomimetic agents. Avoid coadministration.

Moderate (6)

Ipratropium Bromide And Albuterol Sulfate + Andthiazide— Non-potassium sparing diuretics can worsen ECG changes and hypokalemia induced by β-agonists, especially at higher doses…
Ipratropium Bromide And Albuterol Sulfate + Bromide— Drug Interactions Anticholinergic agents : Although ipratropium bromide is minimally absorbed into the systemic circulat…
Ipratropium Bromide And Albuterol Sulfate + Diuretics— Non-potassium sparing diuretics can worsen ECG changes and hypokalemia caused by beta-agonists. Monitor potassium levels…
Ipratropium Bromide And Albuterol Sulfate + Estrogens— Mutual inhibition of effects; β-blockers should be used cautiously in hyperreactive airways patients, with preference fo…
Ipratropium Bromide And Albuterol Sulfate + Loop Diuretics— Non-potassium sparing diuretics can worsen ECG changes and hypokalemia induced by β-agonists, especially at higher doses…
Ipratropium Bromide And Albuterol Sulfate + Potassium Supplements— β-agonist can acutely worsen ECG changes and hypokalemia induced by diuretics, especially at higher doses. Caution advis…

Ipratropium Bromide And Albuterol Sulfate + Acidifying Agents⚠️Major

Potential additive interaction with concomitantly used anticholinergic medications, may increase anticholinergic adverse effects. Avoid coadministration.

Ipratropium Bromide And Albuterol Sulfate + Monoamine Oxidase Inhibitors (Maois)⚠️Major

Extreme caution advised; action of albuterol on cardiovascular system may be potentiated. Should not be used within 2 weeks of MAOi discontinuation.

Ipratropium Bromide And Albuterol Sulfate + Nonselective Beta-Adrenergic Antagonists⚠️Major

Increased risk of adverse cardiovascular effects with concomitant sympathomimetic agents. Avoid coadministration.

Ipratropium Bromide And Albuterol Sulfate + Andthiazide🟡Moderate

Non-potassium sparing diuretics can worsen ECG changes and hypokalemia induced by β-agonists, especially at higher doses.

Ipratropium Bromide And Albuterol Sulfate + Bromide🟡Moderate

Drug Interactions Anticholinergic agents : Although ipratropium bromide is minimally absorbed into the systemic circulation, there is some potential for an additive interaction with concomitantly used anticholinergic medications. Caution is, therefore, advised in the coadministration of ipratropium bromide and albuterol sulfate with other drugs having anticholinergic properties. ß-adrenergic agents : Caution is advised in the coadministration of ipratropium bromide and albuterol sulfate and other sympathomimetic agents due to the increased risk of adverse cardiovascular effects.

Ipratropium Bromide And Albuterol Sulfate + Diuretics🟡Moderate

Non-potassium sparing diuretics can worsen ECG changes and hypokalemia caused by beta-agonists. Monitor potassium levels.

Ipratropium Bromide And Albuterol Sulfate + Estrogens🟡Moderate

Mutual inhibition of effects; β-blockers should be used cautiously in hyperreactive airways patients, with preference for β1-selective agents.

Ipratropium Bromide And Albuterol Sulfate + Loop Diuretics🟡Moderate

Non-potassium sparing diuretics can worsen ECG changes and hypokalemia induced by β-agonists, especially at higher doses.

Ipratropium Bromide And Albuterol Sulfate + Potassium Supplements🟡Moderate

β-agonist can acutely worsen ECG changes and hypokalemia induced by diuretics, especially at higher doses. Caution advised.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.